Lecture 17: Agents that affect bone mineral homeostasis

Question 1

*Describe in detail the use of SERMs in the management of disease of bone mineral homeostasis. This should include name, indications, adverse effects, contraindications and drug interactions of each member of this drug class.

Answer 1

hj

Question 2

*Describe in detail the mode of action of SERMs in the management of disease of bone mineral homeostasis.

Answer 2

j

Question 3

*Describe in detail the use of bisphosphonates in the management of disease of bone mineral homeostasis. This should include name, indications, adverse effects, contraindications and drug interactions of each member of this drug class.

Answer 3

h

Question 4

*Describe in detail the mode of action of bisphosphonates in the management of disease of bone mineral homeostasis.

Answer 4

j

Question 5

*Describe in detail the use of vitamin D preparations in the management of disease of bone mineral homeostasis. This should include name, indications, adverse effects, contraindications and drug interactions of each member of this drug class.

Answer 5

k

Question 6

*Describe in detail the mode of action of vitamin D preparations in the management of disease of bone mineral homeostasis.

Answer 6

j

Question 7

*Describe in detail the use of tibolone in the management of disease of bone mineral homeostasis. This should include name, indications, adverse effects, contraindications and drug interactions of each member of this drug class.

Answer 7

j

Question 8

*Describe in detail the mode of action of tibolone in the management of disease of bone mineral homeostasis.

Answer 8

j

Question 9

*Describe in detail the use of PTH in the management of disease of bone mineral homeostasis. This should include name, indications, adverse effects, contraindications and drug interactions of each member of this drug class.

Answer 9

j

Question 10

*Describe in detail the mode of action of PTH in the management of disease of bone mineral homeostasis.

Answer 10

x